
Pharmaceutical Executive
Investors welcome biopharma sector initiative.




Pharmaceutical Executive
Welcome to the new look and branding of Pharmaceutical Executive-reimagined to better reflect you, our audience, and expand on the content you've long trusted us to deliver.



Pharmaceutical Executive





ZS offers advice to ensure reps can stay engaged with their customers during these times of changing needs and constraints.

Now officially a worldwide pandemic, the biomedical research community is rushing to develop treatments and preventives to halt the spread and severity of the COVID-19 virus.

Pharmaceutical Executive

Pharmaceutical Executive

Pharmaceutical Executive
Click the title above to open the Pharmaceutical Executive March 2020 issue in an interactive PDF format.

Pharmaceutical Executive
High customer satisfaction and low risk is the goal for patient service programs and is possible with focus on solid service delivery and quality.


Pharmaceutical Executive

Pharmaceutical Executive

The continued COVID-19 outbreak has fueled fears of drug shortages, primarily for active pharmaceutical ingredients produced in China.

Pharmaceutical Executive

Pharmaceutical Executive
With the nomination period for our latest Emerging Pharma Leaders selections in full swing, it's a good reminder that the industry's future path ultimately depends on its leaders, emerging and otherwise.

Pharmaceutical Executive
Key learnings from the BCG Market Access benchmark 2019.


Pharmaceutical Executive
Click the title above to open the Pharmaceutical Executive February 2020 issue in an interactive PDF format.

Pharmaceutical Executive
Hungary is fast staking a reputation for itself as one of Central and Eastern Europe’s most dynamic economies. A major factor has been pharmaceuticals, where Hungary’s history of research and production is reflected today in an attractive pharma investment landscape and the presence of home-grown success stories.

Pharmaceutical Executive
Guidelines on how innovators can assert patents to protect their products’ exclusivity while avoiding claims from competitors and the FTC that their conduct runs afoul of U.S. antitrust law.